ZhuZhou QianJin Pharmaceutical Co Ltd (600479) — Financial Flexibility Index
ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has a Financial Flexibility Index of 0.19x as of September 2025. Free cash flow of CN¥312.72 Million (operating CF CN¥288.83 Million minus capex CN¥23.89 Million) represents 0% of total liabilities (CN¥1.66 Billion). Also explore how fast is ZhuZhou QianJin Pharmaceutical Co Ltd growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ZhuZhou QianJin Pharmaceutical Co Ltd Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for ZhuZhou QianJin Pharmaceutical Co Ltd across 24 annual periods. Check strategic asset allocation of ZhuZhou QianJin Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for ZhuZhou QianJin Pharmaceutical Co Ltd (2002–2025)
Year-by-year free cash flow to debt coverage for ZhuZhou QianJin Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 600479 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.37x | CN¥604.41 Million | CN¥480.24 Million | CN¥1.61 Billion | ▲ +19.0% |
| 2024 | 0.31x | CN¥446.09 Million | CN¥398.77 Million | CN¥1.42 Billion | ▲ +6.6% |
| 2023 | 0.30x | CN¥487.10 Million | CN¥443.12 Million | CN¥1.65 Billion | ▼ -30.1% |
| 2022 | 0.42x | CN¥767.91 Million | CN¥733.47 Million | CN¥1.82 Billion | ▲ +3.1% |
| 2021 | 0.41x | CN¥557.45 Million | CN¥485.57 Million | CN¥1.36 Billion | ▼ -6.0% |
| 2020 | 0.44x | CN¥639.61 Million | CN¥542.37 Million | CN¥1.47 Billion | ▲ +163.0% |
| 2019 | 0.17x | CN¥196.11 Million | CN¥155.49 Million | CN¥1.18 Billion | ▼ -59.8% |
| 2018 | 0.41x | CN¥429.86 Million | CN¥383.47 Million | CN¥1.04 Billion | ▲ +26.5% |
| 2017 | 0.33x | CN¥340.77 Million | CN¥283.47 Million | CN¥1.05 Billion | ▲ +38.9% |
| 2016 | 0.23x | CN¥222.38 Million | CN¥140.88 Million | CN¥948.21 Million | ▲ +20.3% |
| 2015 | 0.20x | CN¥151.96 Million | CN¥67.48 Million | CN¥779.17 Million | ▼ -34.0% |
| 2014 | 0.30x | CN¥249.32 Million | CN¥183.34 Million | CN¥843.20 Million | ▼ -8.9% |
| 2013 | 0.32x | CN¥221.89 Million | CN¥137.63 Million | CN¥683.92 Million | ▼ -58.5% |
| 2012 | 0.78x | CN¥454.08 Million | CN¥197.82 Million | CN¥581.18 Million | ▲ +160.4% |
| 2011 | 0.30x | CN¥86.45 Million | CN¥22.58 Million | CN¥288.10 Million | ▼ -42.0% |
| 2010 | 0.52x | CN¥97.57 Million | CN¥39.13 Million | CN¥188.65 Million | ▼ -17.4% |
| 2009 | 0.63x | CN¥196.85 Million | CN¥73.54 Million | CN¥314.48 Million | ▼ -13.2% |
| 2008 | 0.72x | CN¥132.51 Million | CN¥37.20 Million | CN¥183.66 Million | ▲ +34.2% |
| 2007 | 0.54x | CN¥101.80 Million | CN¥79.26 Million | CN¥189.30 Million | ▼ -35.7% |
| 2006 | 0.84x | CN¥141.51 Million | CN¥120.12 Million | CN¥169.13 Million | ▲ +82.5% |
| 2005 | 0.46x | CN¥93.24 Million | CN¥76.50 Million | CN¥203.38 Million | ▼ -9.2% |
| 2004 | 0.51x | CN¥74.95 Million | CN¥18.45 Million | CN¥148.38 Million | ▲ +11.8% |
| 2003 | 0.45x | CN¥85.01 Million | CN¥50.96 Million | CN¥188.23 Million | ▲ +20.5% |
| 2002 | 0.37x | CN¥65.31 Million | CN¥6.07 Million | CN¥174.31 Million | — |